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Abstract The activation domain of class I aminoacyl-tRNA
synthetases, which contains the Rossmann fold and the signature
sequences HIGH and KMSKS, is generally split into two halves
by the connective peptides (CP1, CP2) whose amino acid se-
quences are idiosyncratic. CP1 has been shown to participate in
the binding of tRNA as well as the editing of the reaction
intermediate aminoacyl-AMP or the aminoacyl-tRNA. No func-
tion has been assigned to CP2. The amino acid sequence of
Acidithiobacillus ferrooxidans TrpRS was predicted from the
genome sequence. Protein sequence alignments revealed that
A. ferrooxidans TrpRS contains a 70 amino acids long CP2
that is not found in any other bacterial TrpRS. However, a
CP2 in the same relative position was found in the predicted
sequence of several archaeal TrpRSs. A. ferrooxidans TrpRS is
functional in vivo in Escherichia coli. A deletion mutant of
A. ferrooxidans trpS lacking the coding region of CP2 was
constructed. The in vivo activity of the mutant TrpRS in
E. coli, as well as the kinetic parameters of the in vitro activa-
tion of tryptophan by ATP, were not altered by the deletion.
However, the Km value for tRNA was seven-fold higher upon
deletion, reducing the e⁄ciency of aminoacylation. Structural
modeling suggests that CP2 binds to the inner corner of the L
shape of tRNA.
/ 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Aminoacyl-tRNA synthetases (AARS) are the key enzymes
to ensure the faithful translation of genetic information. With
the exception of glutamine and asparagine, most organisms
contain at least one copy of the genes encoding the enzymes
that aminoacylate each amino acid to the 3P end of the cog-
nate tRNA. The aminoacylation of tRNA by the synthetases
occurs in a two-step reaction, activation of the amino acid
with ATP and subsequent transfer of the activated residue
to the 3P end of tRNA. At least two domains can be visualized
in all AARS, the activation or catalytic domain and the anti-
codon binding domain. Based on the common structure of the
activation domains, AARS are divided into two classes. In
class I, the active site is composed of a parallel L-sheet £anked
by K-helices at both ends (Rossmann fold). In class II, the
active site is made up of an antiparallel L-sheet [1]. Within the
domains, signature sequences for each class are present
(HIGH and KMSKS for class I and motifs 1, 2 and 3 for
class II).
Beside the conserved signature motifs and structure of class
I AARS, the Rossmann fold is generally separated into two
halves by the presence of two idiosyncratic sequences, named
connective peptides 1 and 2 (CP1, CP2) [2]. Several functions
have been described for CP1. Among them are editing of
mischarged tRNA in LeuRS [3] and IleRS [4,5], although it
is dispensable for the enzymatic activity [6], tRNA binding in
GlnRS [7], species speci¢city between bacterial and eukaryal
TyrRS [8], and zinc binding of cytoplasmic yeast MetRS [9].
To date, no function has been assigned to CP2 of class I
AARS.
The crystal structure of Bacillus stearothermophilus TrpRS
has been solved at a resolution of 1.7 AF [10,11]. TrpRS from
the majority of the organisms of all three domains of life
contains a relatively short CP2. TrpRS from the acidophilic
bacterium Acidithiobacillus ferrooxidans contains an unusually
long CP2. Similar or even longer CP2 domains are found in
some euryarchaeal TrpRS proteins. Here we show that a de-
letion of 65 amino acids from the CP2 in A. ferrooxidans
TrpRS results in an enzyme that retains in vitro and in vivo
activity. Although the shortened TrpRS was fully active in
tryptophan activation, kinetic analysis revealed that the Km
for cognate tRNA was seven-fold higher compared to the
intact enzyme. Modeling of the tertiary structure of A. fer-
rooxidans TrpRS suggests that CP2 might interact with the
tRNA, causing no distortion of the evolutionarily conserved
structure of TrpRS.
2. Materials and methods
2.1. Cloning of trpS from A. ferrooxidans and Escherichia coli
A BLAST search [12] was used to identify the trpS gene in the
genome sequence from A. ferrooxidans using the microbial data-
base of The Institute for Genomic Research (http://www.tigr.org).
The gene was ampli¢ed by PCR from genomic DNA from A. ferro-
oxidans ATCC 19859 using Elongase (Life Technologies) and the
primers WSTF1 (5P-GAATTCTGAGAGAGATCATCGTTTC-3P)
and WSTF2 (5P-GAATTCCGACGCGCCGGATTC3-P). The se-
quence recognized by EcoRI is underlined. The PCR product was
cloned into pGEM-T (Promega). After digestion with EcoRI, the
1236 bp DNA was subcloned into EcoRI-digested pGEX-2T (Phar-
macia). Plasmid pGWSAf-1 was obtained. TrpS from E. coli was also
obtained by PCR ampli¢cation from genomic DNA, using the prim-
ers WSEC1 (5P-TATATAGGATCCTTAACGCTTC3-P) and WSEC2
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(5P-GAATTCTGACTAAGCCCATCG-3P). The DNA product was
digested with BamHI and EcoRI (underlined) and cloned into
pGEX-2T, giving plasmid pTRS. Identity of trpS from pGWSAf-1
and pTRS was con¢rmed by DNA sequencing.
2.2. Deletion of the CP2 encoding segment from A. ferrooxidans trpS
To delete the region encoding 65 amino acids (residues 176^241) of
the domain CP2 from A. ferrooxidans trpS, a modi¢cation of the PCR
mutagenesis procedure was employed [13]. Using plasmid pGWSAf-1,
a ¢rst PCR ampli¢cation of the DNA encoding the 5P (primers
WSTF1 and WSTF3, 5P-AGGATTTCATCGGCGTCGCG-3P) and
3P (primers WSTF2 and WSTF4, 5P-ACGCCGATGAAATCCTT-
CGCGAA-3P) regions adjacent to the segment to be deleted was car-
ried out. Two PCR products were obtained (539 and 520 bp respec-
tively) which have an overlapping region (underlined in the sequence
of primers WSTF3 and WSTF4). These PCR products were used as
template in a second PCR ampli¢cation with the external primers
WSTF1 and WSTF2, to obtain the trpS gene with the deletion in
the CP2 domain. The deleted trpS (trpSN65) was cloned into the
EcoRI site of pGEX-2T giving the plasmid pGWSN65. All DNA
manipulations were con¢rmed by DNA sequencing.
2.3. Complementation of E. coli trp42c
E. coli strain trp42c [14], which carries a thermosensitive mutation
in trpS, was transformed by electroporation with the desired plasmid
(pGWSAf-1, pGWSN65, pTRS or pGEX-2T), plated on LB ampicillin
(100 Wg/ml) and incubated for 16 h at 30‡C. Isolated colonies were
inoculated into 1 ml of LB ampicillin and cultivated for 16 h at 30‡C.
This culture was used to inoculate 10 ml of LB ampicillin to obtain an
absorbance at 600 nm of 0.1 and then transferred to 40‡C. Cell pro-
liferation was monitored by measuring absorbance at 600 nm.
2.4. Preparation of A. ferrooxidans tRNATrp
The sequence of the A. ferrooxidans tRNATrp gene was obtained
from The Institute of Genome Research Microbial Database. The gene
was constructed by chemical synthesis (Centro de S|¤ntesis y Ana¤lisis
de Biomole¤culas, Universidad de Chile) including EcoRI and HindIII
sites at the 5P and 3P £anking regions respectively. The arti¢cial gene
was cloned into pKK223-3 (Amersham Pharmacia Biotech), generat-
ing the plasmid pKK-tRNATrp. The identity of the cloned gene was
con¢rmed by DNA sequencing. E. coli DH5K was transformed by
electroporation with the recombinant plasmid. Transformed cells
were grown to an absorbance of 0.8 at 600 nm and the expression
of the tRNA gene was initiated by the addition of 1 mM IPTG. The
cells were further cultured for 3 h at 37‡C. Puri¢cation of the tRNA
from these cells was carried out according to the procedure described
by Raczniack et al. [15]. Using glutathione S-transferase (GST)^
TrpRS from E. coli as a source of TrpRS, the tRNA preparation
aminoacylated 16.3 pmol of tryptophan per Wg of total E. coli
tRNA, compared to 0.057 pmol per Wg of total tRNA obtained
when tRNA from cells transformed with the empty vector was used.
2.5. In vitro enzymatic activity of recombinant TrpRSs
Recombinant TrpRS from A. ferrooxidans (GST^TrpRS and GST^
TrpRSN65) and E. coli (TrpRS) were expressed in E. coli JM105.
Puri¢cation and enzymatic analyses of all TrpRSs fused to gluta-
thione transferase were carried out as described previously [16].
3. Results
3.1. TrpRS sequence and modeling
A BLAST similarity search of the sequence of B. stearother-
mophilus TrpRS against the A. ferrooxidans genome sequence
(The Institute of Genome Research Microbial Database) re-
vealed an open reading frame encoding a 403 amino acids
long protein. The predicted protein sequence aligns with
TrpRS from di¡erent species. The encoded protein contains
the signature motifs of class I AARS and a 70 amino acids
long CP2 that is unusually long for TrpRS. When the se-
quence of the CP2 was excluded from the alignment, the high-
est score was obtained with Thermotoga maritima TrpRS
(52% identity and 70% similarity). Neither evident pro-
moter(s) nor b-independent transcription terminators were
found 400 nucleotides upstream or downstream of the trpS
gene respectively.
Alignment of TrpRS sequences encoded in the genome of
organisms from all three phylogenetic domains revealed that
the CP2 is not present in any other bacterial or eukaryal
TrpRS (Fig. 1). However, the predicted sequence of some
archaeal TrpRS of Euryarchaeota also contain a CP2 (59^
129 amino acids long) in the same relative position as in
A. ferrooxidans (based on the predicted protein sequence
alignment). At the amino acid level, these putative CP2s
have low sequence similarity (data not shown).
The structure of B. stearothermophilus TrpRS has been
solved at 1.7 AF resolution. This is a dimer of two identical
subunits [11]. Based on the similarity of amino acid sequence,
B. stearothermophilus TrpRS was used as template to model
the three-dimensional structure of A. ferrooxidans TrpRS. In
order to model properly, the sequence of the putative CP2
was excluded from the procedure. The predicted three-dimen-
sional structure has an root mean square deviation of 0.58 AF
compared to B. stearothermophilus TrpRS (data not shown).
Residues which are known to interact with the intermediate
tryptophanyl-AMP in B. stearothermophilus have similar dis-
tances in the model. Secondary structure analysis revealed
that 83% of amino acids present favorable P and i angles.
These observations support the prediction that the structure
of A. ferrooxidans TrpRS might be similar to B. stearother-
mophilus TrpRS (data not shown). Based on the predicted
Fig. 1. Schematic representation of the alignment of TrpRSs sequences from organisms representative of the three domains of life. Conserved
regions (white), CP2 (black) and extensions at the amino-terminus of archaeal and eukaryal TrpRS (stippled) are represented. Thin lines repre-
sent the connection between contiguous sequences. All TrpRS are aligned based on the HIGH and KMSKS signature motifs. Anticodon bind-
ing site (ABS) and CP2 relative positions are indicated.
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structure, CP2 is localized near the interface of the two sub-
units of the dimer.
3.2. CP2 is dispensable for A. ferrooxidans TrpRS activity
To further biochemically and genetically characterize
TrpRS, the gene encoding A. ferrooxidans TrpRS was cloned
in pGEX-2T, which allows the expression of TrpRS fused to
GST under the control of isopropyl-L-galactoside.
A deletion of the DNA segment encoding residues 176^241
of TrpRS (65 out of 70 residues of CP2) was carried out.
Functionality of recombinant wild type (trpS) and deleted
(trpSN65) genes was tested by rescuing the thermosensitive
phenotype of E. coli trp42c. Both wild type A. ferrooxidans
trpS and trpSN65 successfully suppressed the mutation at the
non-permissive temperature (Fig. 2). These results indicate
that A. ferrooxidans TrpRS can recognize E. coli tRNA and
that CP2 is not essential for the in vivo activity of the enzyme
in E. coli.
3.3. Is CP2 from A. ferrooxidans TrpRS involved in the
aminoacylation of tRNA?
To further characterize the biochemical properties of re-
combinant A. ferrooxidans GST^TrpRS and GST^TrpRSN65,
protein products were overexpressed in E. coli and puri¢ed by
a⁄nity chromatography on glutathione-agarose. As both fu-
sion products were mostly insoluble even when the cells were
cultivated at 25‡C, the yield in the puri¢cation procedure was
only 0.028 mg and 0.024 mg per liter of culture for GST^
TrpRS and GST^TrpRSN65 respectively. Recombinant E. coli
trpS, cloned in the same DNA vector, yielded 7.6 mg of the
fusion product GST^TrpRS per liter of culture.
Both GST^TrpRS and GST^TrpRSN65 activate tryptophan
practically at the same rate, as measured by the PPi exchange
assay (Table 1). While the deletion causes no changed in the
Km for tryptophan, Km for ATP and kcat are slightly altered.
As the kinetic parameters of the activation reaction are similar
in the wild type and the deleted variant of TrpRS, we assume
that the structure of the activation domain is not modi¢ed
upon deletion of CP2. Activation of 5-£uorotryptophan, an
analog that has been described as more hydrophobic than
tryptophan [17], was also not a¡ected by the deletion on
A. ferrooxidans TrpRS (data not shown), supporting that
the deletion caused no e¡ect on the active site of the enzyme.
The e¡ect of the fusion of GST to TrpRS was analyzed in
E. coli TrpRS fused to GST. Kinetic parameters of recombi-
nant E. coli TrpRS were similar to the reported values of the
wild type enzyme (Table 1) [14], suggesting that the fusion to
glutathione transferase has no e¡ect on the catalytic proper-
ties of the enzymes.
A total tRNA preparation from E. coli that overexpressed
A. ferrooxidans tRNATrp was used as substrate for the amino-
acylation reaction. Kinetic analysis of the aminoacylation of
tRNATrp revealed that TrpRSN65 has a Km which is seven-
fold higher compared to wild type TrpRS (Table 1). A slight
decrease in kcat of aminoacylation led to a 10-fold decrease in
the catalytic e⁄ciency of the overall reaction. These results
imply that the CP2 from A. ferrooxidans TrpRS might partic-
ipate in the binding of tRNA to the enzyme. Whether there is
a direct e¡ect of CP2 on the binding of tRNATrp or the
observed increase in Km is due to a global change in the
protein structure upon the deletion is yet to be elucidated.
4. Discussion
The presence of a remarkably long CP2 in A. ferrooxidans
TrpRS as well as in some members of the Euryarchaeota in
the same relative position (although with low, if any, sequence
similarity) might indicate that the CP2 present in contempo-
rary TrpRS is a remnant of CP2 from ancient TrpRS in the
process of disappearance. Modeling of the tertiary structure of
A. ferrooxidans TrpRS was possible only when amino acids of
CP2 were excluded from the query sequence. The predicted
structure was found to be similar to B. stearothermophilus
TrpRS. It suggests that CP2 is an appendage on the surface
of the protein and the rest of the enzyme can acquire the
overall conserved structure. A. ferrooxidans TrpRS is active
in vivo in E. coli. It implies that A. ferrooxidans TrpRS uti-
lizes E. coli tRNATrp as substrate. Deletion of CP2 has no
evident e¡ect on the function of the expressed protein in vivo
in E. coli. In vitro kinetic analysis revealed that neither Km of
Fig. 2. Complementation of E. coli trp42c with A. ferrooxidans trpS
variants. E. coli thermosensitive mutant cells were transformed with
plasmids carrying A. ferrooxidans trpS wild type (7) or N65 (E)
genes fused to GST. Cells were grown at the restrictive temperature
and proliferation was monitored by absorbance at 600 nm. a,
empty vector.
Table 1
Kinetic parameters of recombinant TrpRS
Enzyme Activation of tryptophan Aminoacylation of tRNATrp
Km Trp
(WM)
Km ATP
(WM)
kcat
(s31)
kcat/Km Trp
(s31 WM31)
Km tRNATrp
(WM)
kcat
(s31)
kcat/Km tRNATrp
(s31 WM31)
A. ferrooxidans TrpRS wt 1.45 128.6 24.5 16.9 0.31 3.17 10.2
A. ferrooxidans TrpRSN65 1.87 252.2 13.6 7.3 2.02 2.22 1.1
E. coli TrpRS 16.81 ^ 150.6 9.0 0.62 13.9 22.4
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tryptophan and ATP nor kcat for the activation of tryptophan
is substantially a¡ected by the deletion of CP2, suggesting
that the conformation of the activation domain of TrpRS
might not be distorted by the deletion. In contrast, a consid-
erable increase in the Km of the enzyme for the cognate tRNA
was evidenced, with the concomitant e¡ect in the e⁄ciency of
the aminoacylation reaction. The activation domain of class I
synthetases interacts with the acceptor stem of tRNA [7],
which carries the discriminator base located adjacent to the
CCA of tRNA. It seems to be the case with Bacillus subtilis
TrpRS as well [18]. Based on the model of A. ferrooxidans
TrpRS described here and the model of B. subtilis TrpRS^
tRNATrp complex, proposed by Jia et al. [18], we believe that
CP2 is localized close to the inner portion of the L shape of
tRNA. From these assumptions, we hypothesize that CP2
might contribute to facilitate the interaction of A. ferrooxi-
dans TrpRS with tRNATrp.
The observations described in this report raise the question
whether there is any other role of A. ferrooxidans TrpRS in
addition to aminoacylation of tRNATrp. Archaeal tRNATrp
genes contain introns which have to be removed from the
primary transcript RNAs to yield active substrates for TrpRS
[19]. Whether the CP2 from archaeal TrpRS might have a
function in the processing of the tRNA is an alternative to
be investigated. It is interesting to note that BLAST searches
of A. ferrooxidans TrpRS CP2 to protein sequence databases
revealed similarity to a portion of the Rossmann fold of cer-
tain dehydrogenases (data not shown). It has been described
that glyceraldehyde-3-phosphate dehydrogenase from human
cells [20] has, among several other, a speci¢c tRNA binding
activity. NAD inhibited the tRNA binding suggesting that the
Rossmann fold is involved in this activity. Whether the long
CP2 of A. ferrooxidans and archaeal TrpRS plays a role in
functions not yet discovered other than protein synthesis is an
open question.
Acknowledgements: We thank Dr. Dieter Soll for critical review of the
manuscript and Katherine Saub for some experiments. J.S. was the
recipient of a Graduate Student Fellowship by Fondecyt, Chile
(299034). This work was supported by a grant from Fondecyt, Chile
(1981083) to O.O.
References
[1] Delarue, M. and Moras, D. (1993) BioEssays 15, 675^687.
[2] Hou, Y.M., Shiba, K., Mottes, C. and Schimmel, P. (1991) Proc.
Natl. Acad. Sci. USA 88, 976^980.
[3] Mursinna, R.S., Lincecum Jr., T.L. and Martinis, S.A. (2001)
Biochemistry 40, 5376^5381.
[4] Nureki, O., Vassylyev, D.G., Tateno, M., Shimada, A., Nakama,
T., Fukai, S., Konno, M., Hendrickson, T.L., Schimmel, P. and
Yokoyama, S. (1998) Science 280, 578^582.
[5] Silvian, L.F., Wang, J. and Steitz, T.A. (1999) Science 285, 1074^
1077.
[6] Starzyk, R.M., Webster, T.A. and Schimmel, P. (1987) Science
237, 1614^1617.
[7] Rould, M.A., Perona, J.J., So« ll, D. and Steitz, T.A. (1989) Sci-
ence 246, 1135^1142.
[8] Wakasugi, K., Quinn, C., Tao, N. and Schimmel, P. (1998)
EMBO J. 17, 297^305.
[9] Senger, B., Desponds, L., Walter, P., Jakubowski, H. and Fas-
ciolo, F. (2001) J. Mol. Biol. 311, 205^216.
[10] Doublie¤, S., Bricogne, G., Gilmore, C. and Carter Jr., C.W.
(1995) Structure 3, 17^31.
[11] Ilyin, V.A., Temple, B., Hu, M., Li, G., Yin, Y., Vachette, P. and
Carter Jr., C.W. (2000) Protein Sci. 9, 218^231.
[12] Altschul, S.F., Gish, W., Miller, W., Myers, E.W. and Lipman,
D.J. (1990) J. Mol. Biol. 215, 403^410.
[13] Higuchi, P., Krummel, B. and Saiki, R.K. (1988) Nucleic Acids
Res. 16, 7351^7367.
[14] Sever, S., Roger, K., Rogers, M.J., Carter Jr., C. and So« ll, D.
(1996) Biochemistry 35, 32^40.
[15] Raczniak, G., Becker, H.D., Min, B. and So«ll, D. (2001) J. Biol.
Chem. 276, 45862^45867.
[16] Salazar, J.C., Zu¤n‹iga, R., Le¢mil, C., So« ll, D. and Orellana, O.
(2001) FEBS Lett. 491, 257^260.
[17] Xu, Z.J., Love, M.L., Ma, L.Y., Blum, M., Bronskill, P.M.,
Bernstein, J., Grey, A.A., Hofmann, T., Camerman, N. and
Wong, J.T. (1989) J. Biol. Chem. 264, 4304^4311.
[18] Jia, J., Xu, F., Chen, X., Chen, L., Jin, Y. and Wang, D. (2002)
Biochem. J. 365, 749^756.
[19] Daniels, C.J., Gupta, R. and Doolittle, W.F. (1985) J. Biol.
Chem. 260, 3132^3134.
[20] Singh, R. and Green, M. (1993) Science 259, 365^368.
FEBS 26813 4-12-02
R. Zu¤n‹iga et al./FEBS Letters 532 (2002) 387^390390
